MARKET WIREYahoo • 2d ago
GEHC vs. HAE: Which Stock Is the Better Value Option?GEHC vs. HAE: Which Stock Is the Better Value Option?
Why HAE Stock advanced +1.24% Today — RQD Quant Desk Flash
$119.79 +1.24% NYSE • Public Delayed / 60s Snapshot
Haemonetics Corporation (HAE) carries a Roarable Rating of C+ (Hold) with 68/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
ROARABLE C+ • HOLD / WATCH
Cap $5.45B
INTERACTIVE SCENARIO DECK:
RQD QUANT TACHOMETERHOLD / WATCH • C+
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
5-PILLAR SNOWFLAKE RADARRw C · Rk B+
Each axis scored 0–20
12M PRICE TARGET CONE+4.5% Base Target
WHALE OPTIONS TUG-OF-WAR:56% Call Buyers ($2.5M)
44% PutsMax Pain: $117.00
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why HAE Stock advanced +1.24% Today — RQD Quant Desk Flash
Haemonetics Corporation (HAE) advanced +1.24% to $119.79 as options desks priced 56% call premium vs. 44% put protection around the $117 max-pain magnet. Solid 59% profit margin (8% return on capital), mixed timing at 185x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 95% of its 52-week range ($49.24 – $123.77) with RSI-14 at 63.3 (BULLISH MOMENTUM).
- ▸Whale Options Positioning: $2.5M in bullish call flow vs. $2.0M in put flow (Put/Call 0.78x, implied earnings swing ±6.9%).
- ▸Fundamental Anchor: Roarable C+ (Hold) backed by 59% gross margin and $260.4M annual free cash flow.
Live HAE Headlines & Catalysts
CATALYSTYahoo • 3d ago
Blood Plasma Name Hits Highs On FDA Approval As Earnings LoomHaemonetics provides tools for blood products management such as plasma collection and providing systems, training and services for blood collection.
CATALYSTYahoo • 3d ago
Haemonetics Corporation (HAE) Gains on Strong Plasma Growth and Higher Guidance, Ariel Appreciation Fund SaysAriel Investments, an investment management company, released its “Ariel Appreciation Fund” Q3 2026 investor letter. A copy of the letter can be downloaded here. Copy main article 1st para. The Fund faced a challenging t
MARKET WIRESeekingAlpha • 4d ago
Ariel Appreciation Fund Q3 2026 Scorecard: Buys, Sells, And StandoutsAriel Appreciation Fund discusses Q3 2026 performance and portfolio adjustments including spin-offs. Read the full analysis for more details.
CATALYSTYahoo • 4d ago
All You Need to Know About Haemonetics (HAE) Rating Upgrade to BuyHaemonetics (HAE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
MARKET WIRESeekingAlpha • 5d ago
Riverwater Partners Sustainable Value Strategy Q3 2026 Portfolio UpdateCATALYSTFintel • 9d ago
Haemonetics Consensus Price Target Raised 24.88% to $145.63MARKET WIREYahoo • 10d ago
Haemonetics (HAE): Buy, Sell, or Hold Post Q2 Earnings?Haemonetics has been on fire lately. In the past six months alone, the company’s stock price has rocketed 96.3%, reaching $118.21 per share. This was partly thanks to its solid quarterly results, and the run-up might hav
CATALYSTYahoo • 12d ago
Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50-Day LineStock Preachers News Commentary - Big tech drove a sharp rebound into the close, with the Nasdaq Composite up 1.11% and the S&P 500 up 0.66% on the session, while the Dow Jones Industrial Average slipped 0.07% and settle
CATALYSTYahoo • 12d ago
Haemonetics Announces FDA Approval of PerQseal® Elite Vascular Closure SystemHaemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced U.S. Food and Drug Administration (FDA) approval o
🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Trading Systems Desk
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live HAE Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
RQD INSIDER CLUB UPGRADE$49/YEAR
Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?
HAE // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +99.12%▲ ASCENDING CHANNEL
2026-10-30O $120.5H $120.5L $118.4C $119.7VOL 453.3K
RES: $128.9SUP: $109.5SMA50: $110.0SMA200: $78.64
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
HAE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
48.0%/yr Implied 5Y Growth
vs. -2.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on HAE today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for HAE. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for HAE today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
HAE Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is HAE stock moving today?
Why HAE Stock advanced +1.24% Today — RQD Quant Desk Flash. Solid 59% profit margin (8% return on capital), mixed timing at 185x P/E—hold if owned, no rush to chase.